Sudeshna Rakshit

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Circulating Tumor Cells

Dna Methylation

Coronary Artery Disease

Top Venues

Medical oncology (Northwood, London, England)

Molecular biology reports

Journal of cancer research and clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Sohini Roy, Geetha Shanmugam, Sudeshna Rakshit, R Pradeep, Melvin George, Koustav Sarkar
Exploring the immunomodulatory potential of Brahmi (Bacopa monnieri) in the treatment of invasive ductal carcinoma. Medical oncology (Northwood, London, England) 41 (5) (2024)
Sohini Roy, Geetha Shanmugam, Sudeshna Rakshit, R Pradeep, Melvin George, Koustav Sarkar
Exploring the immunomodulatory potential of Brahmi (Bacopa monnieri) in the treatment of invasive ductal carcinoma. Medical oncology (Northwood, London, England) 41 (5) (2024)
Sohini Roy, Geetha Shanmugam, Sudeshna Rakshit, R Pradeep, Melvin George, Koustav Sarkar
Exploring the immunomodulatory potential of Brahmi (Bacopa monnieri) in the treatment of invasive ductal carcinoma. Medical oncology (Northwood, London, England) 41 (5) (2024)
Sannidhi Bhootra, Nandana Jill, Geetha Shanmugam, Sudeshna Rakshit, Koustav Sarkar
DNA methylation and cancer: transcriptional regulation, prognostic, and therapeutic perspective. Medical oncology (Northwood, London, England) 40 (2) (2023)
Sannidhi Bhootra, Nandana Jill, Geetha Shanmugam, Sudeshna Rakshit, Koustav Sarkar
DNA methylation and cancer: transcriptional regulation, prognostic, and therapeutic perspective. Medical oncology (Northwood, London, England) 40 (2) (2023)
Nikhil Chandnani, Vedika Shrirang Choudhari, Rajat Talukdar, Sudeshna Rakshit, Geetha Shanmugam, Shiuli Guchait, Ishika Gupta, Melvin George, Koustav Sarkar
Depletion of enhancer zeste homolog 2 (EZH2) directs transcription factors associated with T cell differentiation through epigenetic regulation of Yin Yang 1(YY1) in combating non-small cell lung cancer (NSCLC). Medical oncology (Northwood, London, England) 40 (7) (2023)
Nikhil Chandnani, Vedika Shrirang Choudhari, Rajat Talukdar, Sudeshna Rakshit, Geetha Shanmugam, Shiuli Guchait, Ishika Gupta, Melvin George, Koustav Sarkar
Depletion of enhancer zeste homolog 2 (EZH2) directs transcription factors associated with T cell differentiation through epigenetic regulation of Yin Yang 1(YY1) in combating non-small cell lung cancer (NSCLC). Medical oncology (Northwood, London, England) 40 (7) (2023)
Sannidhi Bhootra, Nandana Jill, Geetha Shanmugam, Sudeshna Rakshit, Koustav Sarkar
DNA methylation and cancer: transcriptional regulation, prognostic, and therapeutic perspective. Medical oncology (Northwood, London, England) 40 (2) (2023)
Sudeshna Rakshit, Jithin S Sunny, Melvin George, Hanna Elizabeth Luke, K V Leela, Koustav Sarkar
T helper cell-mediated epitranscriptomic regulation via m6A RNA methylation bridges link between coronary artery disease and invasive ductal carcinoma. Journal of cancer research and clinical oncology 148 (12) (2022)
Riasha Pal, Nilanjan Paul, Deep Bhattacharya, Sudeshna Rakshit, Geetha Shanmugam, Koustav Sarkar
XPG in the Nucleotide Excision Repair and Beyond: a study on the different functional aspects of XPG and its associated diseases. Molecular biology reports 49 (8) (2022)
Sudeshna Rakshit, Geetha Shanmugam, Koustav Sarkar
Coronary artery disease and cancer: a significant resemblance. Medical oncology (Northwood, London, England) 39 (12) (2022)
Geetha Shanmugam, Sumana Das, Sambuddha Paul, Sudeshna Rakshit, Koustav Sarkar
Clinical relevance and therapeutic aspects of professional antigen-presenting cells in lung cancer. Medical oncology (Northwood, London, England) 39 (12) (2022)